- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06216912
Gastric Volume in Paralyzed Obese Patients After High-flow Nasal Oxygen Therapy
January 17, 2024 updated by: Seoul National University Hospital
Ultrasound Assessment of Gastric Volume in Paralyzed Obese Patients After High-flow Nasal Oxygen Therapy
Preoperative preoxygenation is performed using HFNOT, and the gastric volume before and after HFNOT is measured by ultrasound and compared in obese patients undergoing surgery under general anesthesia.
Study Overview
Status
Not yet recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Tae Kyong Kim
- Phone Number: 82-2-870-2519
- Email: ktkktk@gmail.com
Study Locations
-
-
-
Seoul, Korea, Republic of, 07061
- SMG - SNU Boramae Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Obese patients undergoing surgery under general anesthesia
Description
Inclusion Criteria:
- Adult patients with a BMI of 30 kg/m2 or more, undergoing surgery under general anesthesia
Exclusion Criteria:
- Nasotracheal intubation
- History of a surgery or anatomical anomaly in the head and neck
- History of Inability to breathe through nose
- History of difficult airway
- Severe cardiac or respiratory disease
- Gastric reflux disease, diabetes, pregnancy
- Previous gastric surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
gastric volume measured by gastric ultrasound
Time Frame: immediately before HFNOT, immediately after HFNOT, immediately after tracheal intubation
|
gastric volume measured by gastric ultrasound
|
immediately before HFNOT, immediately after HFNOT, immediately after tracheal intubation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
January 10, 2024
Primary Completion (Estimated)
January 1, 2025
Study Completion (Estimated)
January 31, 2025
Study Registration Dates
First Submitted
January 3, 2024
First Submitted That Met QC Criteria
January 17, 2024
First Posted (Actual)
January 22, 2024
Study Record Updates
Last Update Posted (Actual)
January 22, 2024
Last Update Submitted That Met QC Criteria
January 17, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HFNOT_gastric
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Undefined
-
Methodist Health SystemRecruiting
-
Consorci Sanitari de l'Alt Penedès i GarrafRecruiting
-
October 6 UniversityRecruiting
-
MyMD Pharmaceuticals, Inc.Completed
-
Indonesia UniversityCompleted
-
Memorial Sloan Kettering Cancer CenterRecruitingGraft-Versus-Host Disease | GVHD | UndefinedUnited States
-
Airway Therapeutics, Inc.TerminatedCOVID-19 | UndefinedUnited States
-
National Defense Medical Center, TaiwanCompletedAnxiety | Acute Myocardial Infarction | Mobile Health | Self-efficacy | Undefined | Cardio-respiratory FitnessTaiwan
-
Fundación Pública Andaluza para la gestión de la...RecruitingPulmonary Disease | Pulmonary Embolism | Deep Venous Thrombosis | Respiratory Disease | Venous Thromboembolic Disease | Screening | UndefinedSpain
-
Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of MedicineTerminatedSevere Combined Immunodeficiency Disease | Severe Primary Immunodeficiency Disorder | Undefined T Cell Deficiency Disorder | Wiskott-Aldrick SyndromeUnited States